Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
暂无分享,去创建一个
L. Chiche | J. Pers | A. Saraux | V. Devauchelle-Pensec | J. Berthelot | E. Hachulla | S. Jousse-Joulin | P. Marcorelles | D. Cornec | P. Hatron | V. Goeb | O. Vittecoq | S. Costa